The efficacy of etanercept as anti-breast cancer treatment is attenuated by residing macrophages

BACKGROUND: Interaction between microenvironment and breast cancer cells often is not considered at the early stages of drug development leading to failure of many drugs at later clinical stages. Etanercept is a TNF-alpha inhibitor that has been investigated for potential antitumor effect in breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirmohammadi, Elnaz, Ebrahimi, Seyed-Esmaeil Sadat, Farshchi, Amir, Salimi, Mona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469281/
https://www.ncbi.nlm.nih.gov/pubmed/32883235
http://dx.doi.org/10.1186/s12885-020-07228-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469281/
https://www.ncbi.nlm.nih.gov/pubmed/32883235
http://dx.doi.org/10.1186/s12885-020-07228-y

Ejemplares similares